FDA denial could delay launch of Minerva’s schizophrenia treatment roluperidone by at least two years: GlobalData Read more
We have attempted to make the dengue vaccine more affordable than other innovative vaccines Read more
FOPE request govt for funding to MSME to upgrade manufacturing facilities for revised Schedule M Read more